LEE KENNETH B JR has filed 4 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 16745 shares of BIOCRYST PHARMACEUTICALS INC ($BCRX) on June 13, 2023.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | LEE KENNETH B JR | Director | A | Common Stock | 16745 | $0.00 | 68,863.0000 | 185,908,000 | 32.13% | 0.01% |
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | LEE KENNETH B JR | Director | A | Automatic Stock Option Grant | 39072 | $0.00 | 39,072.0000 | 185,908,000 | 9999.99% | 0.02% |
| Jan. 31, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | LEE KENNETH B JR | Director | M | Common Stock | 15000 | $1.71 | 52,118.0000 | 185,908,000 | 40.41% | 0.01% |
| Jan. 31, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | LEE KENNETH B JR | Director | M | Automatic Stock Option Grant | 15000 | $0.00 | 0.0000 | 185,908,000 | 100.00% | 0.01% |